Viroseq HIV-1 GT V2 genotype
Ended Awarded
- Contract number
- 0003
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $129,396
Award facts
- Contract value 100% obligated
- $129,396.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The order is for VIROSEQ HIV-1 GT V2 GENOTYPE services, with an ultimate completion date of July 7, 2016 and a ceiling value of $129,396.00. The contract does not have a set-aside designation. Abbott Molecular has held several IDIQ contracts and BPAs with federal agencies, including the VA and Army MEDCOM, to provide a range of molecular diagnostics equipment, reagents, and testing services to support their clinical and research needs.
Quick answers
Who was awarded contract 0003?
0003 was awarded to Abbott Molecular Inc. by Medical Command (Department of the Army) on June 29, 2016.
How much is contract 0003 worth?
The government has obligated $129,396 on 0003.
Is contract 0003 an order under another contract?
Yes. 0003 is a BPA call under W81XWH15A0013, a blanket purchase agreement.
Was contract 0003 competed?
The extent of competition for 0003 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award